Zur Kurzanzeige

2018-05-31Zeitschriftenartikel DOI: 10.25646/5598
Travel-associated hepatitis A in Europe, 2009 to 2015
dc.contributor.authorBeauté, Julien
dc.contributor.authorWestrell, Therese
dc.contributor.authorSchmid, Daniela
dc.contributor.authorMüller, Luise
dc.contributor.authorEpstein, Jevgenia
dc.contributor.authorKontio, Mia
dc.contributor.authorCouturier, Elisabeth
dc.contributor.authorFaber, Mirko
dc.contributor.authorMellou, Kassiani
dc.contributor.authorBorg, Maria-Louise
dc.contributor.authorFriesema, Ingrid
dc.contributor.authorVold, Line
dc.contributor.authorSeveri, Ettore
dc.date.accessioned2018-06-01T05:58:59Z
dc.date.available2018-06-01T05:58:59Z
dc.date.issued2018-05-31none
dc.identifier.other10.2807/1560-7917.ES.2018.23.22.1700583
dc.identifier.urihttp://edoc.rki.de/176904/5673
dc.description.abstractBackground: Travel to countries with high or intermediate hepatitis A virus (HAV) endemicity is a risk factor for infection in residents of countries with low HAV endemicity. Aim:  The objective of this study was to estimate the risk for hepatitis A among European travellers using surveillance and travel denominator data.  Methods:  We retrieved hepatitis A surveillance data from 13 European Union (EU)/ European Economic Area (EEA) countries with comprehensive surveillance systems and travel denominator data from the Statistical Office of the European Union. A travel-associated case of hepatitis A was defined as any case reported as imported. Results: From 2009to2015, the 13 countries reported 18,839 confirmed cases of hepatitis A, of which 5,233 (27.8%) were travel-associated. Of these, 39.8% were among children younger than 15 years. The overall risk associated with travel abroad decreased over the period at an annual rate of 3.7% (95% confidence interval (CI): 0.7–2.7) from 0.70 cases per million nights in 2009 to 0.51 in 2015. The highest risk was observed in travellers to Africa (2.11 cases per million nights). Cases more likely to be reported as travel-associated were male and of younger age (<25 years). Conclusion: Travel is still a major risk factor for HAV infection in the EU/EEA, although the risk of infection may have slightly decreased in recent years. Children younger than 15 years accounted for a large proportion of cases and should be prioritised for vaccination.eng
dc.language.isogernone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleTravel-associated hepatitis A in Europe, 2009 to 2015none
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/5673-4
dc.identifier.doihttp://dx.doi.org/10.25646/5598
dc.type.versionpublishedVersionnone
local.edoc.container-titleEuroSurveillancenone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.22.1700583none
local.edoc.container-publisher-nameECDCnone
local.edoc.container-volume23none
local.edoc.container-issue22none
local.edoc.container-reportyear2018none
local.edoc.container-firstpage1none
local.edoc.container-lastpage9none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige